The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
20 among them to receive $20,000 grants
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
Subscribe To Our Newsletter & Stay Updated
